Credit Suisse analyst Andrew Kuske downgrades Boralex (TSX:BLX) from Outperform to Neutral.
Biofrontera Inc. Fully Exercises Recently Acquired Options To Purchase Shares Of Biofrontera AG
Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today the exercise in full of options to purchase 2,623,365 ordinary shares of
